Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05402839

Screening of Malignant Hyperthermia Susceptible Individuals

Sponsor: Peking University Third Hospital

View on ClinicalTrials.gov

Summary

This study intends to target patients who underwent surgery under general anesthesia during the study period and developed malignant hyperthermia during or after surgery. Therefore, the total sample size was estimated to be about 50 people based on the past incidence of this rare disease. Every year, about 20 patients and their families who developed malignant hyperthermia during or after surgery will participate in this nationwide study (estimated by the current incidence of malignant hyperthermia), and about 1-5 patients will be admitted to Peking University Third Hospital participate in this research. Relevant specimens were collected from malignant hyperthermia (MH) patients and their family members for genetic analysis to determine the mutation of MH-related pathogenic gene loci.

Official title: Molecular Genetics Study on Screening of Malignant Hyperthermia Susceptible Individuals

Key Details

Gender

All

Age Range

0 Years - 100 Years

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2022-02-22

Completion Date

2041-02

Last Updated

2022-06-02

Healthy Volunteers

No

Locations (1)

Peking University Third Hospital

Beijing, Beijing Municipality, China